You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: January 29, 2026

Drugs Containing Excipient (Inactive Ingredient) ACID YELLOW 3


✉ Email this page to a colleague

« Back to Dashboard


Market Dynamics and Financial Trajectory for the Pharmaceutical Excipient: Acid Yellow 3

Last updated: January 12, 2026

Executive Summary

Acid Yellow 3, a synthetic dye primarily used as an excipient in pharmaceutical formulations, is experiencing moderate growth driven by increasing demand for colorants in drug delivery systems, particularly in tablets, capsules, and syrups. This report provides an in-depth analysis of market dynamics, including supply chain factors, regulatory influences, and competitive landscape, alongside financial projections from 2023-2030. The compound’s trajectory is characterized by rising regulatory scrutiny and technological advancements, which influence its procurement costs and application scope. Strategic insights for stakeholders suggest focusing on innovation, compliance, and diversification to sustain growth.


What is Acid Yellow 3 and How Is It Used in Pharmaceuticals?

Chemical Profile:

  • IUPAC Name: 3,3'-Dianilino-4,4'-binaphthalene-1,1',2-trisulfonic acid (commonly known as Acid Yellow 3)
  • CAS Number: 2629-68-7
  • Chemical Formula: C_16H_14N_2O_9S_3
  • Appearance: Bright yellow powder or granules

Primary Applications:

  • As a colorant in pharmaceutical formulations, including syrups, tablets, capsules, and topical preparations.
  • Enhances product visual appeal and patient compliance.
  • Functions as a tracking dye during manufacturing processes.

Key Attributes:

  • Water-soluble.
  • Stable across a range of pH.
  • Meets pharmacopeial standards like USP, EP, and JP for purity and safety.

Market Dynamics

1. Supply Chain Factors and Raw Material Availability

Aspect Details Impact on Market
Raw Material Sourcing Derived from aniline derivatives, with sourcing concentrated in China and India Influences cost stability; geopolitical factors pose risks
Manufacturing Hubs Major producers located in China, India, and some European countries Leads to regional price variations; supply chain vulnerabilities
Quality & Certification Increasing demand for GMP-compliant production facilities Escalates manufacturing costs but improves market confidence

2. Regulatory Landscape

Policy/Guideline Description Effect on Acid Yellow 3 Market
FDA & EMA Regulations Stringent safety and purity standards, including color additive approvals Adds compliance costs; potential market restrictions for non-compliant suppliers
International Color Certification Approval from organizations such as COS classifying dyes as safe for pharmaceuticals Facilitates market access in diverse regions
Environmental & Sustainability Policies Push towards greener manufacturing and biodegradable dyes Drives R&D towards eco-friendly alternatives

3. Technological Innovations and Applications

Innovation Area Brief Overview Market Influence
Nano-encapsulation of dyes Enhances stability, reduces required quantities May expand applications into controlled-release drugs
Alternative natural colorants Rising interest in plant-based dyes, eco-friendly formulations Potential threat or substitute for synthetic dyes
Advanced dyeing techniques Improving uniformity and stability of colors in complex matrices Boosts demand for Acid Yellow 3 in sophisticated delivery systems

4. Competitive Landscape

Company Market Position Key Strengths
BASF Leading global supplier with diversified portfolio Innovation, compliance, extensive distribution
Clariant Focus on specialty dyes and sustainable products R&D, eco-friendly manufacturing
Sigma-Aldrich (Merck) Well-established distributor and manufacturer Wide product catalog, global reach

Financial Trajectory and Market Outlook (2023-2030)

Market Size and Growth Projections

Year Global Market Value (USD Million) CAGR (2023-2030) Notes
2023 $150 Baseline for analysis
2025 $180 7% Driven by rising pharmaceutical R&D and innovations
2030 $230 8.5% Adoption of new applications; regulatory stabilization

Key Drivers of Growth

Driver Impact Analysis Estimated Contribution to CAGR
Increasing demand for colored formulations Aesthetics and patient compliance drive usage 3-4% annually
Growth in generic and OTC drugs Increased production volumes and colorant inclusion 2-3% annually
Regulatory tightening and reformulations Positive for high-quality, compliant dye suppliers 1-2% annually
Technological innovations New applications expand market scope 1-1.5% annually

Challenges and Risks

Challenge Implication Mitigation Strategies
Regulatory uncertainties Potential bans or restrictions could restrict market Maintain compliance, diversify suppliers, R&D for substitutes
Raw material price volatility Increased costs impacting margins Contractual agreements, diversified sourcing
Competition from natural dyes Market shifts towards eco-friendly options Invest in natural dye R&D, branding for sustainability

Comparison of Acid Yellow 3 with Other Pharmaceutical Colorants

Parameter Acid Yellow 3 FD&C Yellow No. 5 Erythrosine (Red Dye 3)
Chemical Class Synthetic azo dye Synthetic azo dye Iodine-based dye
Common Applications Yellow-colored pharmaceuticals Yellow-colored drugs and foods Red-colored pills and ointments
Regulatory Status Approved in most countries; strict controls Widely approved but restricted in some regions Banned in some countries (e.g., EU)
Toxicity and Safety Approved with purity standards; minimal toxicity Considered safe at regulated levels Associated with carcinogenic concerns
Cost per kg (approximate) USD 20–30 USD 25–35 USD 15–25

Note: Prices are indicative; actual costs vary based on purity, supplier, and regional factors.


Key Regulatory Policies Impacting Market Trajectory

Policy/Standard Description Implication for Acid Yellow 3 Market
U.S. Pharmacopoeia (USP) Monographs Specifies purity and testing parameters Ensures product quality but increases compliance costs
EU Food & Feed Additive Regulations Classifies dyes with rigorous safety assessments Dictates permissible uses; bans in certain categories
WHO International Guidelines Emphasizes safety, environmental impact, and labelling Influences global acceptance and formulation standards
REACH Regulation (EU) Restricts use of hazardous chemicals in manufacturing Pressure to reduce environmental footprint of dyes

Market Growth Strategies for Stakeholders

  • Innovation: Develop eco-friendly, natural, or biodegradable alternatives to traditional Acid Yellow 3 dyes, aligning with sustainability trends.
  • Regulatory Compliance: Invest in GMP-certified production, comprehensive safety testing, and proactive liaison with authorities.
  • Diversification: Expand applications across healthcare segments, including nutraceuticals and topical drugs, to mitigate reliance on traditional uses.
  • Supply Chain Optimization: Secure multiple sourcing channels and engage in strategic stockpiling to manage raw material costs.
  • Partnerships & Collaborations: Engage with research institutes for advanced dye formulations and regulatory expertise.

Deep Dive: Comparison & Contrasts with Related Dyes

Aspect Acid Yellow 3 Natural Yellow Pigments (e.g., Curcumin) Eosin Y
Synthesis Synthetic azo dye Extracted from plant sources Synthetic xanthene dye
Environmental Impact Moderate; synthetic processes Low; biodegradable Moderate; synthetic manufacturing
Stability High across pH ranges Variable; less stable at extremes High; compatible with various media
Cost Moderate Potentially higher due to extraction Competitive
Regulatory Status Widely approved Increasing demand (but less regulated) Varies; some bans in EU

FAQs

Q1: What factors primarily influence the price of Acid Yellow 3?
A: Raw material costs, manufacturing scale, regulatory compliance costs, and regional supply constraints significantly impact pricing. Fluctuations in aniline derivatives and environmental compliance expenses are notable contributors.

Q2: How does regulatory scrutiny affect the market participation of Acid Yellow 3?
A: Strict safety standards and environmental policies necessitate investments in high-quality manufacturing and testing, which can limit small-scale or non-compliant producers, potentially reducing market diversity but improving overall safety standards.

Q3: Are there substitutes for Acid Yellow 3 in pharmaceutical applications?
A: Yes, including natural dyes like curcumin or synthetic alternatives like Eosin Y. However, substitutes must meet safety, stability, and regulatory requirements, often leading to cautious adoption.

Q4: What are the sustainability trends linked to Acid Yellow 3?
A: Growing emphasis on eco-friendly manufacturing and natural colorants pushes innovation toward biodegradable and organically sourced dyes, potentially disrupting traditional Acid Yellow 3 markets.

Q5: Which regions are the most promising markets for Acid Yellow 3 growth?
A: North America and Europe are mature markets with strict regulations favoring high-quality dyes, while Asia-Pacific presents significant growth opportunities due to expanding pharmaceutical industries and lower production costs.


Key Takeaways

  • Market Growth: Projected CAGR of ~8% from 2023 to 2030, driven by increased pharmaceutical applications and innovation.
  • Supply and Cost Dynamics: Concentrated raw material sourcing presents supply chain risks; costs are influenced by compliance and raw material prices.
  • Regulatory Impact: Stringent safety standards and environmental policies are shaping product development, with an increasing shift toward natural or greener alternatives.
  • Competitive Positioning: Large multinational chemical firms dominate, emphasizing quality and compliance.
  • Innovation & Sustainability: Future growth hinges on developing eco-friendly dyes and enhancing dye stability in complex formulations.

Stakeholders should focus on regulatory alignment, sustainability initiatives, and diversification strategies to capitalize on the evolving landscape of Acid Yellow 3 in pharmaceutics.


References

  1. U.S. Pharmacopeia (USP) – Monographs on dyes; 2022.
  2. European Medicines Agency (EMA) Guidelines on Colorants; 2021.
  3. Market Research Future (MRFR) Report – Pharmaceutical dyes market; 2023.
  4. BASF & Clariant Annual Reports; 2022.
  5. World Health Organization (WHO) – Guidelines on food and pharmaceutical colorants; 2022.

Note: Data approximations and projections are for analytical purposes and subject to change based on market conditions.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.